Respiratory Health · 7 min read

E-Cigarettes: A Safer Alternative or a New Kind of Trap?

Published June 2025 · 5 sources reviewed

What We're Actually Inhaling

The promise was straightforward: e-cigarettes deliver nicotine without the combustion products that make traditional cigarettes deadly. No tar, no carbon monoxide, no thousands of carcinogens from burning tobacco. On that narrow claim, there is scientific consensus — vaping is, by most measurements, less harmful than smoking conventional cigarettes. But "less harmful than cigarettes" is a remarkably low bar, and the full picture is considerably more complicated.

The aerosol produced by e-cigarettes is not "harmless water vapor," as early marketing claimed. It contains fine and ultrafine particles, heavy metals including lead, nickel, and chromium leached from heating coils, volatile organic compounds, and flavoring chemicals — some of which are safe to eat but hazardous when inhaled repeatedly over years. Diacetyl, a buttery-flavored compound used in many vaping liquids, was already known to cause bronchiolitis obliterans, a severe and irreversible lung condition, from occupational exposure in microwave popcorn factories.

The long-term health effects of vaping remain genuinely uncertain, because the products haven't existed long enough to generate decades-long outcome data. What we have is concerning: studies linking regular vaping to increased cardiovascular risk, impaired immune response in the airways, and significant nicotine dependence. The 2019 EVALI outbreak — e-cigarette or vaping product use-associated lung injury — hospitalized over 2,800 people in the US and killed 68. While EVALI was linked primarily to vitamin E acetate in illicit THC cartridges, the episode revealed how quickly a widely used inhalation product can produce a novel disease pattern.

"We've essentially conducted a mass experiment on an entire generation of young lungs. The data on long-term outcomes won't fully arrive for another decade — and by then, the damage will have already been done to millions of people who started vaping as teenagers."
— Dr. Stanton Glantz, Professor of Medicine, UCSF Center for Tobacco Research

The adolescent uptake dimension is perhaps the most significant. JUUL Labs, which at its peak held over 70% of the US e-cigarette market, designed its products with nicotine salt formulations that deliver nicotine more efficiently and with less harshness than traditional cigarettes — making it easier for first-time users to establish dependence. By 2018, 1 in 5 US high school students reported vaping in the past month. A generation that had largely rejected cigarettes found itself heavily dependent on nicotine through a different delivery mechanism.

From the Courtroom

In 2022, JUUL Labs agreed to pay $438.5 million to settle investigations by 33 US states over its marketing practices. The settlement found that JUUL had specifically targeted minors through social media campaigns using youthful imagery and influencer partnerships, distributed free samples at youth-attended events, and marketed products with flavors — mango, cucumber, crème brûlée — demonstrably more appealing to adolescents than to adult smokers trying to quit.

Separately, JUUL paid $1.2 billion to settle over 5,000 personal injury lawsuits from individuals claiming the company had caused their nicotine addiction or health conditions. The FDA also blocked JUUL from the US market in 2022, citing insufficient evidence of benefit and evidence of genotoxicity — though this order was later stayed pending review.

Altria, the tobacco giant that had acquired a 35% stake in JUUL for $12.8 billion in 2018, eventually wrote down that investment to near zero — a remarkable outcome for a product that had been publicly described as a potential solution to tobacco-related disease.

FactoraHealth Comparison Table

The Claim	What the Science Says
"Just harmless water vapor"	Aerosol contains heavy metals, fine particles, and volatile organics — not water vapor
"Safer than cigarettes"	Likely true on combustion products, but long-term risks are unestablished and distinct harms documented
"Effective quit-smoking tool"	Some evidence for cessation support; most users end up dual-using or switching dependence rather than quitting
"Not addictive for young users"	Nicotine salt formulations are highly addictive; adolescent brains are especially vulnerable to nicotine dependence

So What Should We Make of This?

The honest answer is that e-cigarettes occupy a genuinely contested space in public health. For a confirmed, motivated adult smoker who has failed other cessation methods, they may represent a meaningful harm reduction tool. Public Health England's estimate — that vaping is "at least 95% less harmful than smoking" — is frequently cited, though it has also been criticized for weak evidence and conflicts of interest among the authors.

What is not in reasonable dispute is this: e-cigarettes are not a consumer health product in the way marketing has portrayed them. They deliver a highly addictive drug via an incompletely characterized aerosol, using devices that were unregulated for years, to a market that systematically included teenagers. The aggregate cost of that experiment — in addiction, in health outcomes, in legal liability — is still being tallied.

If you don't currently smoke, there is no benefit from vaping and meaningful risk. If you do smoke, the calculus is more complex — and worth having with a physician, not a marketing campaign.